Some of the health policies coming out of Washington, DC, are clever, but there might be too much coming out for practices to keep up with, said Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
Some of the health policies coming out of Washington, DC, are clever, but there might be too much coming out for practices to keep up with, said Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
Transcript
Is the fact that there is so much payment reform coming out of Washington, DC, a good thing or a bad thing?
It’s so interesting because not a week goes by that something comes out. And in my other jobs in my career I didn’t spend very much time thinking about Washington. Somehow I got into this job now where I spend a lot of time thinking about what happens in Washington. I love the concept that people are willing to talk about disruption. I think some of the ideas that are coming out haven’t been fully thought through. I think some of them are kind of clever. I think there are unintended consequences and I hope they’re wise enough to ask people who are open-minded and thoughtful, and well-versed about what the unintended consequences are before they pull the trigger, so to speak.
I call it job security actually because everybody wants to know what I think about this, and so that’s really good. But I think practices can’t possibly keep up with this. There’s too much going on and trying to understand how it would affect me in upstate New York or wherever. I think there will be a shockwave in oncology, community oncology, even hospital-based and academic programs because these programs, they’re cross-cutting. They affect everybody. OCM affected everybody and IPI will affect everybody, CAP will affect everybody so we’ll see how it plays out.
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More